Search - tctmd.com

Displaying 81 - 100 of 319

Sort: Relevancy | Date

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

News Conference News TCT 2020

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

October 15, 2020

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

News Daily News

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

October 09, 2020

Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions

News Daily News

Making Sense of MI: EXCEL and SYNTAX Tackle Event Definitions

Michael O'Riordan

September 28, 2020

Document Proposes Procedure Volumes to Attain Competency in High-risk PCI

News Daily News

Document Proposes Procedure Volumes to Attain Competency in High-risk PCI

September 22, 2020

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

News Daily News

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

September 17, 2020

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

News Conference News ESC 2020

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

Yael L. Maxwell

September 08, 2020

For Cardiac CT, COVID-19 Has Toppled Silos and Paved the Way for Change

News Conference News SCCT 2020

For Cardiac CT, COVID-19 Has Toppled Silos and Paved the Way for Change

Yael L. Maxwell

July 28, 2020

ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT

News Conference News SCCT 2020

ISCHEMIA, Patient Age in PROMISE Among Top CT Papers of the Year at SCCT

Yael L. Maxwell

July 20, 2020

Complete Revascularization in STEMI Seems to Cut CV Mortality: Meta-analysis

News Daily News

Complete Revascularization in STEMI Seems to Cut CV Mortality: Meta-analysis

May 27, 2020

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

News Daily News

Clopidogrel Holds Advantage in Older NTSE ACS Patients: POPular AGE Published

Michael O'Riordan

April 27, 2020

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

News Features

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

April 23, 2020

SCAD Readmissions Common After Acute MI, Especially in Young Women

News Daily News

SCAD Readmissions Common After Acute MI, Especially in Young Women

April 20, 2020

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

News

As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMI

Michael O'Riordan

April 17, 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan

April 02, 2020

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

News Conference News ACC 2020

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

March 31, 2020

Same Care, Same Outcomes for Women and Men After AMICS

News Daily News

Same Care, Same Outcomes for Women and Men After AMICS

March 12, 2020

First Point-of-Care hs-Troponin I Assay Matches Lab-Based Tests

News Daily News

First Point-of-Care hs-Troponin I Assay Matches Lab-Based Tests

March 10, 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

News Conference News CRT 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Michael O'Riordan

February 25, 2020

News Daily News

No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry

January 15, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.